|
시장보고서
상품코드
2049572
락토페린 시장 보고서 : 기능별, 용도별, 지역별(2026-2034년)Lactoferrin Market Report by Function, Application, and Region 2026-2034 |
||||||
세계의 락토페린 시장 규모는 2025년에 3억 2,710만 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 5억 4,360만 달러에 달하고, 2026년부터 2034년까지 CAGR 5.81%로 성장할 것으로 예측했습니다.
락토페린은 사람이나 소의 모유, 타액, 눈물, 담즙, 점액 등에 널리 존재하는 다기능성 당단백질입니다. 혈액 내 철 이온과 결합하여 체내로 운반하는 역할을 합니다. 또한 항산화 물질이 풍부하게 함유되어 있어 면역력 향상과 세균 및 바이러스 감염 예방에 도움이 됩니다. 또한, 유전자 변형 쌀에서도 상업적으로 추출하여 위궤양, 장궤양, 설사, C형 간염 치료제의 단백질 보충제로 사용되고 있습니다. 락토페린은 조직 손상과 암 예방, 철분 대사 조절, 노화로 인한 손상 감소에도 도움이 됩니다. 그 결과, 제약, 식음료, 뉴트리슈티컬, 퍼스널케어 제품 등 다양한 산업 분야에서 폭넓게 활용되고 있습니다.
전 세계적으로 세균 및 바이러스 감염증의 발병률이 증가하고 있는 것은 시장 성장을 이끄는 주요 요인 중 하나입니다. 락토페린은 뼈와 관절의 치유를 촉진하고 각종 질환으로 인한 골량 감소를 예방합니다. 또한, 일반인들의 건강에 대한 인식이 높아지고 락토페린이 함유된 건강기능식품에 대한 수요가 증가하면서 시장 성장에 힘을 보태고 있습니다. 이에 따라 락토페린은 여드름 치료, 항알레르기, 항노화 등 유익한 특성을 가지고 있어 다양한 화장품 및 퍼스널케어 제품 제조에도 널리 활용되고 있습니다. 또한 피부 병변의 치유를 돕는 결합조직과 표피세포를 자극하여 피부 병변의 치유를 돕습니다. 또한, 락토페린이 강화된 유아용 조제분유 출시 등 다양한 제품 혁신도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 또한, 락토페린은 다양한 스포츠 영양 제품 및 기능성 보충제 제조에도 사용되고 있습니다. 소비자의 구매력 향상, 광범위한 연구개발(R&D) 활동 등 다른 요인들도 시장을 더욱 견인할 것으로 예상됩니다.
본 보고서에서 답변하는 주요 질문
- 지금까지의 세계 락토페린 시장 동향은 어떠했으며, 향후 몇 년 동안 어떻게 변화할 것인가?
- COVID-19는 세계 락토페린 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 기능별 시장 분석은 어떻게 이루어지고 있는가?
- 용도별 시장 현황은 어떠한가?
- 이 산업의 가치사슬에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계 락토페린 시장의 구조는 무엇이며, 주요 업체는 누구인가?
- 업계 내 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 락토페린 시장
제6장 시장 내역 : 기능별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 지역별
제9장 SWOT 분석
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KSM 26.06.10The global lactoferrin market size reached USD 327.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 543.6 Million by 2034, exhibiting a growth rate (CAGR) of 5.81% during 2026-2034.
Lactoferrin is a multi-functional glycoprotein commonly found in human and bovine milk, saliva, tears, bile and mucus. It binds with iron ions present in the blood and transports it through the body. It is a rich source of antioxidants and aids in improving immunity and preventing bacterial and viral infections. It is also commercially sourced from genetically modified rice and is used as a protein supplement in pharmaceutical medicines to treat stomach and intestinal ulcers, diarrhea and hepatitis C . Lactoferrin also aids in preventing tissue damage and cancer, regulating iron metabolism and minimizing damage caused by aging. As a result, it finds extensive applications across various industries, including pharmaceuticals, food and beverages, nutraceuticals and personal care products.
The increasing prevalence of bacterial and viral infections across the globe represents one of the key factors driving the growth of the market. Lactoferrin accelerates bone and joints healing and prevents bone loss caused by various medical ailments. Furthermore, rising health consciousness among the masses, along with the increasing demand for lactoferrin-based nutritional supplements, is also driving the market growth. In line with this, lactoferrin is also widely used in the manufacturing of various cosmetics and personal care products due to its beneficial acne-treating, anti-allergic and anti-aging properties. It stimulates connective tissue and epidermal cells that aid in healing skin lesions. Additionally, various product innovations, such as the launch of infant formula fortified with lactoferrin, are acting as other growth-inducing factors. It is also used for the production of various sports nutrition products and functional supplements. Other factors, including the rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
KEY MARKET SEGMENTATION:
Breakup by Function:
- Iron Absorption
- Anti-Inflammatory
- Intestinal Flora Protection
- Antibacterial
- Immune Cell Stimulation
- Antioxidant
- Others
Breakup by Application:
- Food and Beverages
- Infant Formula
- Sports and Functional Foods
- Pharmaceuticals
- Personal Care Products
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bega Cheese Limited, Farbest Brands, Ferrin-Tech LLC, Fonterra Cooperative Group Ltd., Glanbia PLC, Hoogwegt Group B.V., Ingredia SA, Metagenics Inc. (Alticor Inc.), MILEI GmbH (Morinaga Milk Industry Co. Ltd.), Mp Biomedicals LLC (Valiant Co. Ltd.), Saputo Inc., Synlait Milk Limited, Tatura Milk Industries Ltd. and Westland Milk Products.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global lactoferrin market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global lactoferrin market?
- What are the key regional markets?
- What is the breakup of the market based on the function?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global lactoferrin market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Lactoferrin Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Function
- 6.1 Iron Absorption
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Anti-Inflammatory
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Intestinal Flora Protection
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Antibacterial
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Immune Cell Stimulation
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Antioxidant
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by Application
- 7.1 Food and Beverages
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Infant Formula
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Sports and Functional Foods
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pharmaceuticals
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Personal Care Products
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Bega Cheese Limited
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.2 Farbest Brands
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Ferrin-Tech LLC
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.4 Fonterra Cooperative Group Ltd.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Glanbia PLC
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Hoogwegt Group B.V.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7 Ingredia SA
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.8 Metagenics Inc. (Alticor Inc.)
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.9 MILEI GmbH (Morinaga Milk Industry Co. Ltd.)
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.10 Mp Biomedicals LLC (Valiant Co. Ltd.)
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.11 Saputo Inc.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.12 Synlait Milk Limited
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.12.3 Financials
- 13.3.13 Tatura Milk Industries Ltd.
- 13.3.13.1 Company Overview
- 13.3.13.2 Product Portfolio
- 13.3.14 Westland Milk Products
- 13.3.14.1 Company Overview
- 13.3.14.2 Product Portfolio
- 13.3.1 Bega Cheese Limited
